Trials / Unknown
UnknownNCT02752503
Nalmefene in Alcohol Dependence and Borderline Personality Disorder
Open-label Trial on Therapeutic Effect and Tolerability of Nalmefene in Subjects With Alcohol Use Disorder and Comorbid Borderline Personality Disorder
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nalmefene |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-06-01
- First posted
- 2016-04-27
- Last updated
- 2016-04-27
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02752503. Inclusion in this directory is not an endorsement.